Kjell B. Hellum

1.9k total citations
43 papers, 1.4k citations indexed

About

Kjell B. Hellum is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Kjell B. Hellum has authored 43 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 12 papers in Hepatology and 11 papers in Infectious Diseases. Recurrent topics in Kjell B. Hellum's work include Hepatitis C virus research (12 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers) and Antimicrobial Resistance in Staphylococcus (9 papers). Kjell B. Hellum is often cited by papers focused on Hepatitis C virus research (12 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers) and Antimicrobial Resistance in Staphylococcus (9 papers). Kjell B. Hellum collaborates with scholars based in Norway, Sweden and France. Kjell B. Hellum's co-authors include C. O. Solberg, Kristian Bjøro, Olav Dalgård, Kjell Skaug, B Myrvang, Bjørn Myrvang, S Ritland, N Raknerud, H. Bell and Helge Bell and has published in prestigious journals such as The Lancet, Hepatology and Clinical Infectious Diseases.

In The Last Decade

Kjell B. Hellum

43 papers receiving 1.3k citations

Peers

Countries citing papers authored by Kjell B. Hellum

Since Specialization

Citations

This map shows the geographic impact of Kjell B. Hellum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kjell B. Hellum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kjell B. Hellum more than expected).

Fields of papers citing papers by Kjell B. Hellum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kjell B. Hellum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kjell B. Hellum. The network helps show where Kjell B. Hellum may publish in the future.

Co-authorship network of co-authors of Kjell B. Hellum

This figure shows the co-authorship network connecting the top 25 collaborators of Kjell B. Hellum. A scholar is included among the top collaborators of Kjell B. Hellum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kjell B. Hellum. Kjell B. Hellum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response 2007 ·Hepatology ·Olav Dalgård, (unknown), Helmer Ring‐Larsen, Einar S. Björnsson, Mona Holberg‐Petersen, Eva Skovlund, Olle Reichard, B Myrvang, Bo Sundelöf, S Ritland, Kjell B. Hellum, Aril Frydén, Jon Florholmen, Hans Verbaan	135
2	Treatment With Pegylated Interferon and Ribavarin in Hcv Infection With Genotype 2 Or 3 for 14 Weeks: A Pilot Study 2004 ·Hepatology ·Olav Dalgård, Kristian Bjøro, Kjell B. Hellum, Bjørn Myrvang, S Ritland, Kjell Skaug, N Raknerud, Helge Bell	240
3	Exflagellation of Microgametocytes in <i>Plasmodium vivax</i> Malaria: A Diagnostic Conundrum 2004 ·Medical Principles and Practice ·(unknown), Øystein Anders Strand, (unknown), Kjell B. Hellum	7
4	Behandling ved kronisk hepatitt C 2002 ·Tidsskrift for Den Norske Laegeforening ·Helge Bell, Olav Dalgård, Kristian Bjøro, Kjell B. Hellum, Bjørn Myrvang	1
5	Thyroid dysfunction during treatment of chronic hepatitis C with interferon alpha: no association with either interferon dosage or efficacy of therapy 2002 ·Journal of Internal Medicine ·Olav Dalgård, Kristian Bjøro, Kjell B. Hellum, B Myrvang, Trine Bjøro, Egil Haug, H. Bell	80
6	Treatment of Chronic Hepatitis C in Injecting Drug Users: 5 Years’ Follow-Up 2002 ·European Addiction Research ·Olav Dalgård, Kristian Bjøro, Kjell B. Hellum, B Myrvang, Kjell Skaug, (unknown), H. Bell	110
7	Effect of Interferon-α Induction Therapy on Genotype 2b/3a and Low Viral Load Hepatitis C Virus Infection: A Randomized Multicentre Study 2002 ·Scandinavian Journal of Gastroenterology ·Kristian Bjøro, H. Bell, B Myrvang, Kjell Skaug, N Raknerud, Per Sandvei, (unknown), S Ritland, (unknown), (unknown), Kjell B. Hellum	12
8	Effect of Combined Interferon-α Induction Therapy and Ribavirin on Chronic Hepatitis C Virus Infection: a Randomized Multicentre Study 2002 ·Scandinavian Journal of Gastroenterology ·Kristian Bjøro, H. Bell, Kjell B. Hellum, Kjell Skaug, N Raknerud, Per Sandvei, (unknown), A Mæland, (unknown), B Myrvang	59
9	[Treatment of chronic hepatitis C]. 2002 ·PubMed ·Helge Bell, Olav Dalgård, Kristian Bjøro, Kjell B. Hellum, Bjørn Myrvang	3
10	Herpes simplex virus type 2 DNA detected in cerebrospinal fluid of 9 patients with Mollaret's meningitis 1998 ·Acta Neurologica Scandinavica ·Mogens Jensenius, B Myrvang, Gro Leite Størvold, (unknown), Kjell B. Hellum, A L Bruu	34
11	Genotype, Viral Load and Age as Independent Predictors of Treatment Outcome of Interferon-α2a Treatment in Patients with Chronic Hepatitis C 1997 ·Scandinavian Journal of Infectious Diseases ·Helge Bell, Kjell B. Hellum, Stig Harthug, A Mæland, S Ritland, Bjørn Myrvang, Bent von der Lippe, N Raknerud, Kjell Skaug, (unknown), Rolv Skjærven, (unknown), Peter Simmonds	46
12	Prevalence of Hepatitis C Genotypes among Patients with Chronic Hepatitis C in Norway 1996 ·Scandinavian Journal of Infectious Diseases ·Helge Bell, Kjell B. Hellum, Stig Harthug, A Mæland, S Ritland, Bjørn Myrvang, Bent von der Lippe, N Raknerud, Kjell Skaug, (unknown), Peter Simmonds	15
13	Spectrum of disease in bacteraemic patients during aStreptococcus pyogenes serotype M-1 epidemic in Norway in 1988 1992 ·European Journal of Clinical Microbiology & Infectious Diseases ·(unknown), Peter R. Martin, E. Arne Høiby, Alfred Halstensen, (unknown), Kjell B. Hellum, Lars Westlie, Stein Hallan	28
14	The pharmacokinetics of ceftazidime in patients with impaired renal function and concurrent frusemide therapy 1988 ·European Journal of Clinical Pharmacology ·R. A. Walstad, Ketil Dahl, Kjell B. Hellum, (unknown)	7
15	Pharmacokinetics and tissue penetration of ceftazidime: studies on lymph, aqueous humour, skin blister, cerebrospinal and pleural fluid 1983 ·Journal of Antimicrobial Chemotherapy ·R. A. Walstad, Kjell B. Hellum, Sigmund Blika, L. G. Dale, T. A. Fredriksen, (unknown), G. R. Spencer	52
16	Transfer of penicillin G and ampicillin into human skin blisters induced by suction. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·A Schreiner, Kjell B. Hellum, (unknown), Ira Bergman	36
17	GRANULOCYTE FUNCTION IN BACTERIAL INFECTIONS IN MAN 1977 ·Acta Pathologica Microbiologica Scandinavica Section C Immunology ·Kjell B. Hellum, C. O. Solberg	17
18	N.B.T. TEST IN PULMONARY EMBOLISM AND BACTERIAL PNEUMONIA 1974 ·The Lancet ·Kjell B. Hellum, C. O. Solberg	2
19	POSITIVE N.B.T. TEST IN ACUTE VIRAL HEPATITIS 1973 ·The Lancet ·Kjell B. Hellum, C. O. Solberg	8
20	NEUTROPHIL GRANULOCYTE FUNCTION IN BACTERIAL INFECTIONS 1972 ·The Lancet ·C. O. Solberg, Kjell B. Hellum	94

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact